OrbusNeich Medical Group Holdings Limited (HKG:6929)
Hong Kong · Delayed Price · Currency is HKD 4.035
-0.020 (-0.49%)
Aug 21, 2026, 3:59 PM HKT
HKG:6929 Stock Forecast
Stock Price Forecast
According to 2 analysts polled by S&P Global, HKG:6929 stock has a consensus rating of "Strong Buy" and an average price target of $5.61. The average 1-year stock price forecast is 39.03% higher than the current stock price, while the lowest is $5.31 (+31.60%) and the highest is $5.91 (+46.47%).
Price Target: $5.61 (+39.03%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for HKG:6929 stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Sep '24 | Feb '25 | Mar '25 | Aug '25 | Mar '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 1 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Unknown Analyst CICC No rating | CICC | Buy Maintains $5.30 | Buy | Maintains | $5.30 | +31.35% | Aug 15, 2026 |
Financial Forecast
Revenue This Year
203.06M
from 180.45M
Increased by 12.53%
Revenue Next Year
227.94M
from 203.06M
Increased by 12.25%
EPS This Year
0.05
from 0.05
Increased by 4.34%
EPS Next Year
0.06
from 0.05
Increased by 9.34%
EPS and Forward PE are based on non-GAAP adjusted numbers.